Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc. (CATX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
catx · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 11 Wall Street analysts in the past 3 months
Buy
11 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$16.00
Consensus
$13.33
+351.1% upside
Low
$12.00
Median: $12 · Last Close: $2.96
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$13.33
351.1% upside
High Target
$16
441.5%
Low Target
$12
306.1%
Current Price
$2.96
as of today
Based on analyst price targets, the CATX stock price prediction for the next 12 months ranges from $12 to $16. The consensus CATX price forecast of $13.33 implies 351.1% upside from the current price of $2.96.
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $2.81 | ↓ 5.00% |
1-day model range: $2.78–$2.83. Peak: $2.83 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CATX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-05 | BTIG | Maintains | Buy→Buy |
| 2026-05-05 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-20 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-18 | UBS | Maintains | Buy→Buy |
| 2026-03-18 | B. Riley Securities | Maintains | Buy→Buy |
| 2026-03-18 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-17 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-03-17 | BTIG | Maintains | Buy→Buy |
| 2026-01-30 | Wedbush | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Perspective Therapeutics, Inc. (CATX) stock. Of the recent 43 rating actions, 0 were upgrades and 2 were downgrades. 11 analysts currently cover CATX.
Analyst Recommendation Trends
CATX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 97.4% YoY
Revenue Next Year
$0M
↑ 12.7% YoY
EPS This Year
$-1.11
EPS Next Year
$-1.11
↑ 0.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast CATX EPS of $-1.11 for the current fiscal year, based on estimates from 10 analysts. The CATX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CATX stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CATX price target is $13.33 (+351.1% upside), with an analyst consensus of Buy.
The CATX short-term stock prediction for tomorrow is $2.81 (-5.00%).
Perspective Therapeutics, Inc. trades on AMEX under the ticker CATX. The CATX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 82% of covering analysts.
Frequently asked questions
CATX forecast · 8 questionsAccording to 11 Wall Street analysts, the average 12-month CATX price target is $13.33, with a high forecast of $16.00 and a low of $12.00. The median price target is shown in the chart above when available. This implies +351.1% potential upside from the current price of $2.96.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.